Error: Could not add to watchlist. X
+ Watchlist

Titan Pharmaceuticals Inc

TN7:GR
Ticker Change
TN7:GR has changed to a new ticker symbol
EUR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. The company is also developing gene therapy and drug delivery technologies.
Address
400 Oyster Point Boulevard
Suite 505
South San Francisco, CA 94080-1921
United States
Phone
1-650-244-4990
  • Marc Rubin
    Chairman
  • Sunil Bhonsle
    President/CEO
  • Stephen Kilmer
    Investor Relations
Show More